Microglia under psychosocial stressors along the aging trajectory: Consequences on neuronal circuits, behavior, and brain diseases

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 79, Issue , 2017, Pages 27-39

  Tian, Li ^a,b   Hui, Chin Wai ^c   Bisht, Kanchan ^c   Tan, Yunlong ^b   Sharma, Kaushik ^c   Chen, Song ^b,d   Zhang, Xiangyang ^b,e   Tremblay, Marie Eve ^c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b PEKING UNIVERSITY   (China)

^c University Laval   (Canada)

^d BEIJING INSTITUTE FOR BRAIN DISORDERS   (China)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Aging; Inflammation; Microglia neuron interactions; Oxidative stress; Psychosocial stress

Indexed keywords

AUTOPHAGY RELATED PROTEIN 7; CD11B ANTIGEN; CD68 ANTIGEN; CRYOPYRIN; GLYCOPROTEIN P 15095; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11; PURINERGIC P2X RECEPTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; TRANSCRIPTION FACTOR NRF2; TRYPTOPHAN 2,3 DIOXYGENASE; TUMOR NECROSIS FACTOR;

AGING; ANXIETY; ARTICLE; BEHAVIOR ASSESSMENT; BIOACCUMULATION; BRAIN DISEASE; BRAIN REGION; CELL COMMUNICATION; CELL DENSITY; CELL FUNCTION; CELL INTERACTION; CELL STRUCTURE; COGNITION; CONNECTOME; GENE IDENTIFICATION; HUMAN; MENTAL STRESS; MICROGLIA; NERVE CELL PLASTICITY; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; ANIMAL; COMPLICATION; NERVE CELL; NERVE CELL NETWORK; PATHOLOGY; PHYSIOLOGY;

AGING; ANIMALS; BRAIN DISEASES; HUMANS; MICROGLIA; NERVE NET; NEURONS; OXIDATIVE STRESS; STRESS, PSYCHOLOGICAL;

EID: 85009957596     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2017.01.007     Document Type: Article

References (290)

1. Adelson, J.D., et al. Developmental sculpting of intracortical circuits by MHC class I H2-Db and H2-Kb. Cereb. Cortex 26 (2016), 1453–1463.
2. Alboni, S., et al. Fluoxetine treatment affects the inflammatory response and microglial function according to the quality of the living environment. Brain Behav. Immun. 58 (2016), 261–271.
3. Alkadhi, K.A., Chronic psychosocial stress exposes Alzheimer's disease phenotype in a novel at-risk model. Front. Biosci. (Elite Ed.) 4 (2012), 214–229.
4. Alkadhi, K.A., Tran, T.T., Chronic stress decreases basal levels of memory-related signaling molecules in area CA1 of at-risk (subclinical) model of Alzheimer's disease. Mol. Neurobiol. 52 (2015), 93–100.
5. Altuntas, I., et al. Erythrocyte superoxide dismutase and glutathione peroxidase activities, and malondialdehyde and reduced glutathione levels in schizophrenic patients. Clin. Chem. Lab. Med. 38 (2000), 1277–1281.
6. Andreazza, A.C., et al. Oxidative stress markers in bipolar disorder: a meta-analysis. J. Affect. Disord. 111 (2008), 135–144.
7. Arnoux, I., Audinat, E., Fractalkine signaling and microglia functions in the developing brain. Neural Plast., 2015, 2015, 689404.
8. Aschbacher, K., et al. Good stress, bad stress and oxidative stress: insights from anticipatory cortisol reactivity. Psychoneuroendocrinology 38 (2013), 1698–1708.
9. Bachstetter, A.D., et al. Fractalkine and CX 3 CR1 regulate hippocampal neurogenesis in adult and aged rats. Neurobiol. Aging 32 (2011), 2030–2044.
10. Bahceci, B., et al. Prolidase activity and oxidative stress in patients with schizophrenia: a preliminary study. J. Pak. Med. Assoc. 65 (2015), 131–135.
11. Banati, R.B., et al. Cytotoxicity of microglia. Glia 7 (1993), 111–118.
12. Bellinger, D.L., Lorton, D., Autonomic regulation of cellular immune function. Auton. Neurosci. 182 (2014), 15–41.
13. Berk, M., et al. N-acetyl cysteine as a glutathione precursor for schizophrenia—a double-blind, randomized, placebo-controlled trial. Biol. Psychiatry 64 (2008), 361–368.
14. Bhaskar, K., et al. Regulation of tau pathology by the microglial fractalkine receptor. Neuron 68 (2010), 19–31.
15. Biber, K., et al. Central nervous system myeloid cells as drug targets: current status and translational challenges. Nat. Rev. Drug Discov. 15 (2016), 110–124.
16. Bilbo, S.D., Schwarz, J.M., The immune system and developmental programming of brain and behavior. Front. Neuroendocrinol. 33 (2012), 267–286.
17. Bisht, K., et al. Dark microglia: A new phenotype predominantly associated with pathological states. Glia, 2016.
18. Blandino, P. Jr., et al. Gene expression changes in the hypothalamus provide evidence for regionally-selective changes in IL-1 and microglial markers after acute stress. Brain Behav. Immun. 23 (2009), 958–968.
19. Bloomfield, P.S., et al. Microglial activity in people at ultra high risk of psychosis and in schizophrenia: an [(11)C]PBR28 PET brain imaging study. Am. J. Psychiatry 173 (2016), 44–52.
20. Boche, D., et al. TGFbeta1 regulates the inflammatory response during chronic neurodegeneration. Neurobiol. Dis. 22 (2006), 638–650.
21. Brionne, T.C., et al. Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron 40 (2003), 1133–1145.
22. Brown, N.C., Andreazza, A.C., Young, L.T., An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiatry Res. 218 (2014), 61–68.
23. Bruce-Keller, A.J., et al. NOX activity is increased in mild cognitive impairment. Antioxid. Redox Signal. 12 (2010), 1371–1382.
24. Buchanan, J.B., et al. Cognitive and neuroinflammatory consequences of mild repeated stress are exacerbated in aged mice. Psychoneuroendocrinology 33 (2008), 755–765.
25. Bukhtoyarov, O.V., Samarin, D.M., Psychogenic carcinogenesis: carcinogenesis is without exogenic carcinogens. Med. Hypotheses 73 (2009), 531–536.
26. Burke, N.N., et al. Minocycline modulates neuropathic pain behaviour and cortical M1-M2 microglial gene expression in a rat model of depression. Brain Behav. Immun. 42 (2014), 147–156.
27. Calcia, M.A., et al. Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness. Psychopharmacology (Berl), 2016.
28. Capuron, L., Castanon, N., Role of inflammation in the development of neuropsychiatric symptom domains: evidence and mechanisms. Curr. Top. Behav. Neurosci., 2016.
29. Cardona, A.E., et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 9 (2006), 917–924.
30. Carnevale, D., De Simone, R., Minghetti, L., Microglia-neuron interaction in inflammatory and degenerative diseases: role of cholinergic and noradrenergic systems. CNS Neurol. Disord. Drug Targets 6 (2007), 388–397.
31. Castanon, N., Luheshi, G., Laye, S., Role of neuroinflammation in the emotional and cognitive alterations displayed by animal models of obesity. Front. Neurosci., 9, 2015, 229.
32. Ceccatelli, S., et al. Mechanisms and modulation of neural cell damage induced by oxidative stress. Physiol. Behav. 92 (2007), 87–92.
33. Chabry, J., et al. Enriched environment decreases microglia and brain macrophages inflammatory phenotypes through adiponectin-dependent mechanisms: Relevance to depressive-like behavior. Brain Behav. Immun. 50 (2015), 275–287.
34. Charney, D.S., Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. Am. J. Psychiatry 161 (2004), 195–216.
35. Cheret, C., et al. Neurotoxic activation of microglia is promoted by a nox1-dependent NADPH oxidase. J. Neurosci. 28 (2008), 12039–12051.
36. Choi, S.H., et al. Thrombin-induced oxidative stress contributes to the death of hippocampal neurons in vivo: role of microglial NADPH oxidase. J. Neurosci. 25 (2005), 4082–4090.
37. Cohen, S., et al. Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 5995–5999.
38. Cooney, S.J., Bermudez-Sabogal, S.L., Byrnes, K.R., Cellular and temporal expression of NADPH oxidase (NOX) isotypes after brain injury. J. Neuroinflammation, 10, 2013, 155.
39. Cornejo, F., von Bernhardi, R., Age-dependent changes in the activation and regulation of microglia. Adv. Exp. Med. Biol. 949 (2016), 205–226.
40. Costello, D.A., et al. Long term potentiation is impaired in membrane glycoprotein CD200-deficient mice: a role for Toll-like receptor activation. J. Biol. Chem. 286 (2011), 34722–34732.
41. Couch, Y., et al. Microglial activation, increased TNF and SERT expression in the prefrontal cortex define stress-altered behaviour in mice susceptible to anhedonia. Brain Behav. Immun. 29 (2013), 136–146.
42. Cunningham, C.L., Martinez-Cerdeno, V., Noctor, S.C., Microglia regulate the number of neural precursor cells in the developing cerebral cortex. J. Neurosci. 33 (2013), 4216–4233.
43. D'Agostino, P.M., et al. Brain dendritic cells: biology and pathology. Acta Neuropathol. 124 (2012), 599–614.
44. Dantzer, R., et al. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology 36 (2011), 426–436.
45. Davalos, D., et al. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 8 (2005), 752–758.
46. de Pablos, R.M., et al. Chronic stress enhances microglia activation and exacerbates death of nigral dopaminergic neurons under conditions of inflammation. J. Neuroinflammation, 11, 2014, 34.
47. Delgado, M., Ganea, D., Anti-inflammatory neuropeptides: a new class of endogenous immunoregulatory agents. Brain Behav. Immun. 22 (2008), 1146–1151.
48. Delpech, J.C., et al. Microglia in neuronal plasticity: Influence of stress. Neuropharmacology 96 (2015), 19–28.
49. Delpech, J.C., et al. Microglial activation enhances associative taste memory through purinergic modulation of glutamatergic neurotransmission. J. Neurosci. 35 (2015), 3022–3033.
50. Dentesano, G., et al. CD200R1 and CD200 expression are regulated by PPAR-gamma in activated glial cells. Glia 62 (2014), 982–998.
51. Deslauriers, J., et al. Preventive effect of alpha-lipoic acid on prepulse inhibition deficits in a juvenile two-hit model of schizophrenia. Neuroscience 272 (2014), 261–270.
52. Diz-Chaves, Y., et al. Prenatal stress causes alterations in the morphology of microglia and the inflammatory response of the hippocampus of adult female mice. J. Neuroinflammation, 9, 2012, 71.
53. Duman, R.S., Aghajanian, G.K., Synaptic dysfunction in depression: potential therapeutic targets. Science 338 (2012), 68–72.
54. Dungrawala, H., Manukyan, A., Schneider, B.L., Gene regulation: global transcription rates scale with size. Curr. Biol. 20 (2010), R979–R981.
55. Ekdahl, C.T., et al. Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 13632–13637.
56. Ellwanger, J.H., et al. Biological functions of selenium and its potential influence on Parkinson's disease. An. Acad. Bras. Cienc., 2016.
57. Eren, I., Naziroglu, M., Demirdas, A., Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain. Neurochem. Res. 32 (2007), 1188–1195.
58. Espinosa-Oliva, A.M., et al. Stress is critical for LPS-induced activation of microglia and damage in the rat hippocampus. Neurobiol. Aging 32 (2011), 85–102.
59. Feng, Y., Wang, X., Antioxidant therapies for Alzheimer's disease. Oxid. Med. Cell. Longev., 2012, 2012, 472932.
60. Fidler, J.A., et al. Disease progression in a mouse model of amyotrophic lateral sclerosis: the influence of chronic stress and corticosterone. FASEB J. 25 (2011), 4369–4377.
61. Fourgeaud, L., et al. TAM receptors regulate multiple features of microglial physiology. Nature 532 (2016), 240–244.
62. Franco, R., Fernandez-Suarez, D., Alternatively activated microglia and macrophages in the central nervous system. Prog. Neurobiol. 131 (2015), 65–86.
63. Frank, M.G., et al. Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav. Immun. 21 (2007), 47–59.
64. Fuhrmann, M., et al. Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease. Nat. Neurosci. 13 (2010), 411–413.
65. Galasko, D.R., et al. Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures. Arch. Neurol. 69 (2012), 836–841.
66. Galecki, P., et al. Relation between functional polymorphism of catalase gene (− 262C > T) and recurrent depressive disorder. Neuro Endocrinol. Lett. 30 (2009), 357–362.
67. Gautam, M., et al. Role of antioxidants in generalised anxiety disorder and depression. Indian J. Psychiatry 54 (2012), 244–247.
68. Gawali, N.B., et al. Agmatine ameliorates lipopolysaccharide induced depressive-like behaviour in mice by targeting the underlying inflammatory and oxido-nitrosative mediators. Pharmacol. Biochem. Behav. 149 (2016), 1–8.
69. Gawryluk, J.W., et al. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int. J. Neuropsychopharmacol. 14 (2011), 123–130.
70. Gerecke, K.M., et al. Exercise protects against chronic restraint stress-induced oxidative stress in the cortex and hippocampus. Brain Res. 1509 (2013), 66–78.
71. Ginhoux, F., et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330 (2010), 841–845.
72. Giovanoli, S., et al. Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science 339 (2013), 1095–1099.
73. Gitik, M., et al. Myelin down-regulates myelin phagocytosis by microglia and macrophages through interactions between CD47 on myelin and SIRPalpha (signal regulatory protein-alpha) on phagocytes. J. Neuroinflammation, 8, 2011, 24.
74. Gomez-Gonzalez, B., Escobar, A., Prenatal stress alters microglial development and distribution in postnatal rat brain. Acta Neuropathol. 119 (2010), 303–315.
75. Grabert, K., et al. Microglial brain region-dependent diversity and selective regional sensitivities to aging. Nat. Neurosci. 19 (2016), 504–516.
76. Greter, M., et al. Stroma-derived interleukin-34 controls the development and maintenance of Langerhans cells and the maintenance of microglia. Immunity 37 (2012), 1050–1060.
77. Ha, E., et al. Fluoxetine increases the nitric oxide production via nuclear factor kappa B-mediated pathway in BV2 murine microglial cells. Neurosci. Lett. 397 (2006), 185–189.
78. Haarman, B.C., et al. Neuroinflammation in bipolar disorder - a [(11)C]-(R)-PK11195 positron emission tomography study. Brain Behav. Immun. 40 (2014), 219–225.
79. Hanamsagar, R., Bilbo, S.D., Sex differences in neurodevelopmental and neurodegenerative disorders: Focus on microglial function and neuroinflammation during development. J. Steroid Biochem. Mol. Biol. 160 (2016), 127–133.
80. Hanisch, U.K., Kettenmann, H., Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10 (2007), 1387–1394.
81. Harrigan, T.J., et al. Activation of microglia with zymosan promotes excitatory amino acid release via volume-regulated anion channels: the role of NADPH oxidases. J. Neurochem. 106 (2008), 2449–2462.
82. Harrison, J.K., et al. Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 10896–10901.
83. Hashioka, S., et al. Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide. Exp. Neurol. 206 (2007), 33–42.
84. Hastings, T.G., Lewis, D.A., Zigmond, M.J., Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl. Acad. Sci. U. S. A. 93 (1996), 1956–1961.
85. Haynes, S.E., et al. The P2Y(12) receptor regulates microglial activation by extracellular nucleotides. Nat. Neurosci. 9 (2006), 1512–1519.
86. Hellwig, S., et al. Altered microglia morphology and higher resilience to stress-induced depression-like behavior in CX3CR1-deficient mice. Brain Behav. Immun. 55 (2016), 126–137.
87. Heppner, F.L., et al. Activated microglial cells migrate towards sites of excitotoxic neuronal injury inside organotypic hippocampal slice cultures. Eur. J. Neurosci. 10 (1998), 3284–3290.
88. Herrup, K., The case for rejecting the amyloid cascade hypothesis. Nat. Neurosci. 18 (2015), 794–799.
89. Hinwood, M., et al. Evidence that microglia mediate the neurobiological effects of chronic psychological stress on the medial prefrontal cortex. Cereb. Cortex 22 (2012), 1442–1454.
90. Hinwood, M., et al. Chronic stress induced remodeling of the prefrontal cortex: structural re-organization of microglia and the inhibitory effect of minocycline. Cereb. Cortex 23 (2013), 1784–1797.
91. Hoek, R.M., et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science 290 (2000), 1768–1771.
92. Hong, S., Stevens, B., Microglia: phagocytosing to clear, sculpt, and eliminate. Dev. Cell 38 (2016), 126–128.
93. Hong, S., Dissing-Olesen, L., Stevens, B., New insights on the role of microglia in synaptic pruning in health and disease. Curr. Opin. Neurobiol. 36 (2016), 128–134.
94. Hoshiko, M., et al. Deficiency of the microglial receptor CX3CR1 impairs postnatal functional development of thalamocortical synapses in the barrel cortex. J. Neurosci. 32 (2012), 15106–15111.
95. Hou, G., et al. Chronic stress and Parkinson's disease. CNS Neurosci. Ther. 20 (2014), 1–2.
96. Hovatta, I., Barlow, C., Molecular genetics of anxiety in mice and men. Ann. Med. 40 (2008), 92–109.
97. Hovatta, I., et al. Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. Nature 438 (2005), 662–666.
98. Hwang, J., et al. Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants. Neuropharmacology 55 (2008), 826–834.
99. Iwata, M., et al. Psychological stress activates the inflammasome via release of adenosine triphosphate and stimulation of the purinergic type 2X7 receptor. Biol. Psychiatry 80 (2016), 12–22.
100. Jadhav, V.S., Krause, K.H., Singh, S.K., HIV-1 Tat C modulates NOX2 and NOX4 expressions through miR-17 in a human microglial cell line. J. Neurochem. 131 (2014), 803–815.
101. Jangra, A., Sriram, C.S., Lahkar, M., Lipopolysaccharide-induced behavioral alterations are alleviated by sodium phenylbutyrate via attenuation of oxidative stress and neuroinflammatory cascade. Inflammation 39 (2016), 1441–1452.
102. Jenmalm, M.C., et al. Regulation of myeloid cell function through the CD200 receptor. J. Immunol. 176 (2006), 191–199.
103. Jiang, T., et al. TREM2 in Alzheimer's disease. Mol. Neurobiol. 48 (2013), 180–185.
104. Johnson, J.D., Zimomra, Z.R., Stewart, L.T., Beta-adrenergic receptor activation primes microglia cytokine production. J. Neuroimmunol. 254 (2013), 161–164.
105. Jurgens, H.A., Johnson, R.W., Dysregulated neuronal-microglial cross-talk during aging. Stress Inflamm. 233 (2012), 40–48.
106. Jurgens, T., et al. Reconstruction of single cortical projection neurons reveals primary spine loss in multiple sclerosis. Brain 139 (2016), 39–46.
107. Justin Thenmozhi, A., et al. Hesperidin ameliorates cognitive dysfunction, oxidative stress and apoptosis against aluminium chloride induced rat model of Alzheimer's disease. Nutr. Neurosci., 2016.
108. Kerschensteiner, M., Meinl, E., Hohlfeld, R., Neuro-immune crosstalk in CNS diseases. Neuroscience 158 (2009), 1122–1132.
109. Kettenmann, H., et al. Physiology of microglia. Physiol. Rev. 91 (2011), 461–553.
110. Kettenmann, H., Kirchhoff, F., Verkhratsky, A., Microglia: new roles for the synaptic stripper. Neuron 77 (2013), 10–18.
111. Khanzode, S.D., et al. Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep. 8 (2003), 365–370.
112. Kierdorf, K., et al. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat. Neurosci. 16 (2013), 273–280.
113. Kim, S.T., et al. Immobilization stress causes increases in tetrahydrobiopterin, dopamine, and neuromelanin and oxidative damage in the nigrostriatal system. J. Neurochem. 95 (2005), 89–98.
114. Kim, H.J., et al. Deficient autophagy in microglia impairs synaptic pruning and causes social behavioral defects. Mol. Psychiatry, 2016.
115. Kleinschnitz, C., et al. Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol., 8, 2010.
116. Knuesel, I., et al. Maternal immune activation and abnormal brain development across CNS disorders. Nat. Rev. Neurol. 10 (2014), 643–660.
117. Kooi Ong, L., et al. Reconsidering the role of glial cells in chronic stress-induced dopaminergic neurons loss within the substantia nigra? Friend or foe?. Brain Behav. Immun., 2016.
118. Kopp, B.L., Wick, D., Herman, J.P., Differential effects of homotypic vs. heterotypic chronic stress regimens on microglial activation in the prefrontal cortex. Physiol. Behav. 122 (2013), 246–252.
119. Kreisel, T., et al. Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis. Mol. Psychiatry 19 (2014), 699–709.
120. Kuhn, S.A., et al. Microglia express GABA(B) receptors to modulate interleukin release. Mol. Cell. Neurosci. 25 (2004), 312–322.
121. Kulak, A., et al. Redox dysregulation in the pathophysiology of schizophrenia and bipolar disorder: insights from animal models. Antioxid. Redox Signal. 18 (2013), 1428–1443.
122. Kulesskaya, N., et al. Mixed housing with DBA/2 mice induces stress in C57BL/6 mice: implications for interventions based on social enrichment. Front. Behav Neurosci., 8, 2014, 257.
123. Kunz, M., et al. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 32 (2008), 1677–1681.
124. Laskaris, L.E., et al. Microglial activation and progressive brain changes in schizophrenia. Br. J. Pharmacol. 173 (2016), 666–680.
125. Lavoie, S., et al. Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients. Neuropsychopharmacology 33 (2008), 2187–2199.
126. Lee, H., et al. Synapse elimination and learning rules co-regulated by MHC class I H2-Db. Nature 509 (2014), 195–200.
127. Lee, Y.Y., et al. Anti-inflammatory and antioxidant mechanism of tangeretin in activated microglia. J. Neuroimmune Pharmacol. 11 (2016), 294–305.
128. Lehmann, M.L., et al. Social defeat induces depressive-like states and microglial activation without involvement of peripheral macrophages. J. Neuroinflammation, 13, 2016, 224.
129. Lemaire, V., et al. Prenatal stress produces learning deficits associated with an inhibition of neurogenesis in the hippocampus. Proc. Natl. Acad. Sci. U. S. A. 97 (2000), 11032–11037.
130. Lemke, G., Biology of the TAM receptors. Cold Spring Harb. Perspect. Biol., 5, 2013, a009076.
131. Li, B., et al. NOX4 expression in human microglia leads to constitutive generation of reactive oxygen species and to constitutive IL-6 expression. J. Innate Immun. 1 (2009), 570–581.
132. Li, Z., et al. Microglia are polarized to M1 type in high-anxiety inbred mice in response to lipopolysaccharide challenge. Brain Behav. Immun. 38 (2014), 237–248.
133. Lim, C.M., et al. Fluoxetine affords robust neuroprotection in the postischemic brain via its anti-inflammatory effect. J. Neurosci. Res. 87 (2009), 1037–1045.
134. Linnartz, B., Neumann, H., Microglial activatory (immunoreceptor tyrosine-based activation motif)- and inhibitory (immunoreceptor tyrosine-based inhibition motif)-signaling receptors for recognition of the neuronal glycocalyx. Glia 61 (2013), 37–46.
135. Liston, C., Gan, W.B., Glucocorticoids are critical regulators of dendritic spine development and plasticity in vivo. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 16074–16079.
136. Liu, D., et al. Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells. Neuropharmacology 61 (2011), 592–599.
137. Luo, J., et al. Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival. J. Exp. Med. 210 (2013), 157–172.
138. Ma, L., et al. Differential expression of brain immune genes and schizophrenia-related behavior in C57BL/6N and DBA/2J female mice. Psychiatry Res. 226 (2015), 211–216.
139. Ma, L., et al. Association of brain immune genes with social behavior of inbred mouse strains. J. Neuroinflammation, 12, 2015, 75.
140. Machado, A., et al. Chronic stress as a risk factor for Alzheimer's disease. Rev. Neurosci. 25 (2014), 785–804.
141. Magalhaes, P.V., et al. Antioxidant treatments for schizophrenia. Cochrane Database Syst. Rev., 2, 2016, Cd008919.
142. Maggi, L., et al. LTP impairment by fractalkine/CX3CL1 in mouse hippocampus is mediated through the activity of adenosine receptor type 3 (A3R). J. Neuroimmunol. 215 (2009), 36–42.
143. Maggi, L., et al. CX(3)CR1 deficiency alters hippocampal-dependent plasticity phenomena blunting the effects of enriched environment. Front. Cell. Neurosci., 5, 2011, 22.
144. Martelli, D., et al. Reflex control of inflammation by sympathetic nerves, not the vagus. J. Physiol. 592 (2014), 1677–1686.
145. Masood, A., et al. Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice. J. Pharmacol. Exp. Ther. 326 (2008), 369–379.
146. McEwen, B.S., Gould, E.A., Sakai, R.R., The vulnerability of the hippocampus to protective and destructive effects of glucocorticoids in relation to stress. Br. J. Psychiatry Suppl., 1992, 18–23.
147. McEwen, B.S., et al. Mechanisms of stress in the brain. Nat. Neurosci. 18 (2015), 1353–1363.
148. McKim, D.B., et al. Sympathetic release of splenic monocytes promotes recurring anxiety following repeated social defeat. Biol. Psychiatry, 2015.
149. McKim, D.B., et al. Neuroinflammatory dynamics underlie memory impairments after repeated social defeat., 36, 2016, 2590–2604.
150. McPherson, C.A., Aoyama, M., Harry, G.J., Interleukin (IL)-1 and IL-6 regulation of neural progenitor cell proliferation with hippocampal injury: differential regulatory pathways in the subgranular zone (SGZ) of the adolescent and mature mouse brain. Brain Behav. Immun. 25 (2011), 850–862.
151. Mead, E.L., et al. Microglial neurotransmitter receptors trigger superoxide production in microglia; consequences for microglial-neuronal interactions. J. Neurochem. 121 (2012), 287–301.
152. Mecocci, P., Polidori, M.C., Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease. Biochim. Biophys. Acta 1822 (2012), 631–638.
153. Meuth, S.G., et al. CNS inflammation and neuronal degeneration is aggravated by impaired CD200-CD200R-mediated macrophage silencing. J. Neuroimmunol. 194 (2008), 62–69.
154. Michalakeas, C.A., et al. Effects of sertraline on circulating markers of oxidative stress in depressed patients with chronic heart failure: a pilot study. J. Card. Fail. 17 (2011), 748–754.
155. Milior, G., et al. Fractalkine receptor deficiency impairs microglial and neuronal responsiveness to chronic stress. Brain Behav. Immun., 2015.
156. Miller, A.H., Raison, C.L., The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat. Rev. Immunol. 16 (2016), 22–34.
157. Miller, M.W., Sadeh, N., Traumatic stress, oxidative stress and post-traumatic stress disorder: neurodegeneration and the accelerated-aging hypothesis. Mol. Psychiatry 19 (2014), 1156–1162.
158. Mizuno, T., et al. Interleukin-34 selectively enhances the neuroprotective effects of microglia to attenuate oligomeric amyloid-beta neurotoxicity. Am. J. Pathol. 179 (2011), 2016–2027.
159. Mo, C., Renoir, T., Hannan, A.J., Effects of chronic stress on the onset and progression of Huntington's disease in transgenic mice. Neurobiol. Dis. 71 (2014), 81–94.
160. Monif, M., et al. The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore. J. Neurosci. 29 (2009), 3781–3791.
161. Morgan, J.T., et al. Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol. Psychiatry 68 (2010), 368–376.
162. Moy, S.S., et al. Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav. Brain Res. 176 (2007), 4–20.
163. Mozhui, K., et al. Strain differences in stress responsivity are associated with divergent amygdala gene expression and glutamate-mediated neuronal excitability. J. Neurosci. 30 (2010), 5357–5367.
164. Murray, P.J., et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41 (2014), 14–20.
165. Nalecz, K.A., et al. Carnitine: transport and physiological functions in the brain. Mol. Aspects Med. 25 (2004), 551–567.
166. Neefjes, J., et al. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat. Rev. Immunol. 11 (2011), 823–836.
167. Nelson, L.H., Lenz, K.M., Microglia depletion in early life programs persistent changes in social, mood-related, and locomotor behavior in male and female rats. Behav. Brain Res. 316 (2017), 279–293.
168. Neumann, H., et al. Neurotrophins inhibit major histocompatibility class II inducibility of microglia: involvement of the p75 neurotrophin receptor. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 5779–5784.
169. Niraula, A., Sheridan, J.F., Godbout, J.P., Microglia priming with aging and stress. Neuropsychopharmacology 42 (2017), 318–333.
170. Norton, S., et al. Potential for primary prevention of Alzheimer's disease: an analysis of population-based data. Lancet Neurol. 13 (2014), 788–794.
171. Nunes, S.O., et al. The shared role of oxidative stress and inflammation in major depressive disorder and nicotine dependence. Neurosci. Biobehav. Rev. 37 (2013), 1336–1345.
172. Offen, D., et al. Prevention of dopamine-induced cell death by thiol antioxidants: possible implications for treatment of Parkinson's disease. Exp. Neurol. 141 (1996), 32–39.
173. Onasanwo, S.A., et al. Inhibition of neuroinflammation in BV2 microglia by the biflavonoid kolaviron is dependent on the Nrf2/ARE antioxidant protective mechanism. Mol. Cell. Biochem. 414 (2016), 23–36.
174. Orihuela, R., McPherson, C.A., Harry, G.J., Microglial M1/M2 polarization and metabolic states. Br. J. Pharmacol. 173 (2016), 649–665.
175. Oxenkrug, G.F., Tryptophan kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later. Isr. J. Psychiatry Relat. Sci. 47 (2010), 56–63.
176. Ozcan, M.E., et al. Antioxidant enzyme activities and oxidative stress in affective disorders. Int. Clin. Psychopharmacol. 19 (2004), 89–95.
177. Pacelli, C., et al. Elevated mitochondrial bioenergetics and axonal arborization size are key contributors to the vulnerability of dopamine neurons. Curr. Biol. 25 (2015), 2349–2360.
178. Paolicelli, R.C., et al. Synaptic pruning by microglia is necessary for normal brain development. Science 333 (2011), 1456–1458.
179. Paolicelli, R.C., Bisht, K., Tremblay, M.E., Fractalkine regulation of microglial physiology and consequences on the brain and behavior. Front. Cell. Neurosci., 8, 2014, 129.
180. Parkhurst, C.N., et al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 155 (2013), 1596–1609.
181. Pearson-Leary, J., Osborne, D.M., McNay, E.C., Role of glia in stress-induced enhancement and impairment of memory. Front. Integr. Neurosci., 9, 2015, 63.
182. Pettegrew, J.W., Levine, J., McClure, R.J., Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression. Mol. Psychiatry 5 (2000), 616–632.
183. Pfau, M.L., Russo, S.J., Peripheral and central mechanisms of stress resilience. Neurobiol. Stress 1 (2015), 66–79.
184. Pfeiffer, T., Avignone, E., Nägerl, U.V., Induction of hippocampal long-term potentiation increases the morphological dynamics of microglial processes and prolongs their contacts with dendritic spines. Sci. Rep., 6, 2016, 32422.
185. Polidori, M.C., Nelles, G., Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease - challenges and perspectives. Curr. Pharm. Des. 20 (2014), 3083–3092.
186. Prenderville, J.A., et al. Adding fuel to the fire: the impact of stress on the ageing brain. Trends Neurosci. 38 (2015), 13–25.
187. Prinz, M., Priller, J., Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease. Nat. Rev. Neurosci. 15 (2014), 300–312.
188. Ramirez, K., et al. Imipramine attenuates neuroinflammatory signaling and reverses stress-induced social avoidance. Brain Behav. Immun. 46 (2015), 212–220.
189. Ramirez, K., Niraula, A., Sheridan, J.F., GABAergic modulation with classical benzodiazepines prevent stress-induced neuro-immune dysregulation and behavioral alterations. Brain Behav. Immun. 51 (2016), 154–168.
190. Ranjekar, P.K., et al. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res. 121 (2003), 109–122.
191. Ransohoff, R.M., A polarizing question: do M1 and M2 microglia exist?. Nat. Neurosci. 19 (2016), 987–991.
192. Ransohoff, R.M., How neuroinflammation contributes to neurodegeneration. Science 353 (2016), 777–783.
193. Ransohoff, R.M., El Khoury, J., Microglia in health and disease. Cold Spring Harb. Perspect. Biol., 8, 2015.
194. Reader, B.F., et al. Peripheral and central effects of repeated social defeat stress: monocyte trafficking, microglial activation, and anxiety. Neuroscience 289 (2015), 429–442.
195. Reddy, R., Reddy, R., Antioxidant therapeutics for schizophrenia. Antioxid. Redox Signal. 15 (2011), 2047–2055.
196. Reinke, E., Fabry, Z., Breaking or making immunological privilege in the central nervous system: the regulation of immunity by neuropeptides. Immunol. Lett. 104 (2006), 102–109.
197. Reul, J.M., de Kloet, E.R., Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation. Endocrinology 117 (1985), 2505–2511.
198. Ribas, G.S., Vargas, C.R., Wajner, M., L-Carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders. Gene 533 (2014), 469–476.
199. Ribeiro Xavier, A.L., et al. A distinct population of microglia supports adult neurogenesis in the subventricular zone. J. Neurosci. 35 (2015), 11848–11861.
200. Ribeiro, B.M., et al. Evidences for a progressive microglial activation and increase in iNOS expression in rats submitted to a neurodevelopmental model of schizophrenia: reversal by clozapine. Schizophr. Res. 151 (2013), 12–19.
201. Rivas-Arancibia, S., et al. Oxidative stress-dependent changes in immune responses and cell death in the substantia nigra after ozone exposure in rat. Front. Aging Neurosci., 7, 2015, 65.
202. Rodrigues, R., Petersen, R.B., Perry, G., Parallels between major depressive disorder and Alzheimer's disease: role of oxidative stress and genetic vulnerability. Cell. Mol. Neurobiol. 34 (2014), 925–949.
203. Rogers, J.T., et al. CX3CR1 deficiency leads to impairment of hippocampal cognitive function and synaptic plasticity. J. Neurosci. 31 (2011), 16241–16250.
204. Rojo, A.I., et al. Redox control of microglial function: molecular mechanisms and functional significance. Antioxid. Redox Signal. 21 (2014), 1766–1801.
205. Salemme, A., et al. Anti-inflammatory effects and antioxidant activity of dihydroasparagusic acid in lipopolysaccharide-activated microglial cells. Brain Res. Bull. 120 (2016), 151–158.
206. Salter, M.W., Beggs, S., Sublime microglia: expanding roles for the guardians of the CNS. Cell 158 (2014), 15–24.
207. Sapolsky, R.M., Krey, L.C., McEwen, B.S., Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging. J. Neurosci. 5 (1985), 1222–1227.
208. Savage, J.C., et al. Nuclear receptors license phagocytosis by trem2 + myeloid cells in mouse models of Alzheimer's disease. J. Neurosci. 35 (2015), 6532–6543.
209. Schafer, D.P., et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 74 (2012), 691–705.
210. Schiavone, S., et al. Involvement of NOX2 in the development of behavioral and pathologic alterations in isolated rats. Biol. Psychiatry 66 (2009), 384–392.
211. Schiavone, S., et al. NADPH oxidase elevations in pyramidal neurons drive psychosocial stress-induced neuropathology. Transl. Psychiatry, 2, 2012, e111.
212. Schiavone, S., et al. Severe life stress and oxidative stress in the brain: from animal models to human pathology. Antioxid. Redox Signal. 18 (2013), 1475–1490.
213. Schnieder, T.P., et al. Microglia of prefrontal white matter in suicide. J. Neuropathol. Exp. Neurol. 73 (2014), 880–890.
214. Sekar, A., et al. Schizophrenia risk from complex variation of complement component 4. Nature 530 (2016), 177–183.
215. Seo, J.S., et al. NADPH oxidase mediates depressive behavior induced by chronic stress in mice. J. Neurosci. 32 (2012), 9690–9699.
216. Setiawan, E., et al. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiat. 72 (2015), 268–275.
217. Shaftel, S.S., et al. Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. J. Clin. Invest. 117 (2007), 1595–1604.
218. Sheridan, G.K., Murphy, K.J., Neuron-glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage. Open Biol., 3, 2013, 130181.
219. Shi, Q., et al. Complement C3-deficient mice fail to display age-related hippocampal decline. J. Neurosci. 35 (2015), 13029–13042.
220. Sica, A., Mantovani, A., Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122 (2012), 787–795.
221. Sierra, A., et al. Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis. Cell Stem Cell 7 (2010), 483–495.
222. Sierra, A., et al. Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis. Front. Cell. Neurosci., 7, 2013, 6.
223. Sierra, A., et al. Surveillance, phagocytosis, and inflammation: how never-resting microglia influence adult hippocampal neurogenesis. Neural Plast., 2014, 2014, 610343.
224. Sipe, G.O., et al. Microglial P2Y12 is necessary for synaptic plasticity in mouse visual cortex. Nat. Commun., 7, 2016, 10905.
225. Sitta, A., et al. Evidence that L-carnitine and selenium supplementation reduces oxidative stress in phenylketonuric patients. Cell. Mol. Neurobiol. 31 (2011), 429–436.
226. Slusarczyk, J., et al. Prenatal stress is a vulnerability factor for altered morphology and biological activity of microglia cells. Front. Cell. Neurosci., 9, 2015, 82.
227. Sluzewska, A., et al. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann. N. Y. Acad. Sci. 762 (1995), 474–476.
228. Sorce, S., et al. The role of the NADPH oxidase NOX2 in prion pathogenesis. PLoS Pathog., 10, 2014, e1004531.
229. Spires-Jones, T.L., Hyman, B.T., The intersection of amyloid beta and tau at synapses in Alzheimer's disease. Neuron 82 (2014), 756–771.
230. Squarzoni, P., et al. Microglia modulate wiring of the embryonic forebrain. Cell Rep. 8 (2014), 1271–1279.
231. Srivareerat, M., et al. Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease. Biol. Psychiatry 65 (2009), 918–926.
232. Stein-Behrens, B.A., Lin, W.J., Sapolsky, R.M., Physiological elevations of glucocorticoids potentiate glutamate accumulation in the hippocampus. J. Neurochem. 63 (1994), 596–602.
233. Steiner, J., et al. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J. Psychiatr. Res. 42 (2008), 151–157.
234. Stevens, K.E., et al. Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains. Neuropsychopharmacology 15 (1996), 152–162.
235. Stevens, B., et al. The classical complement cascade mediates CNS synapse elimination. Cell 131 (2007), 1164–1178.
236. Sugama, S., et al. Stress induced morphological microglial activation in the rodent brain: involvement of interleukin-18. Neuroscience 146 (2007), 1388–1399.
237. Sugama, S., et al. Chronic restraint stress triggers dopaminergic and noradrenergic neurodegeneration: possible role of chronic stress in the onset of Parkinson's disease. Brain Behav. Immun. 51 (2016), 39–46.
238. 2 + elevation in cultured rat hippocampal neurons. J. Neurochem. 83 (2002), 1441–1451.
239. Takahashi, K., Rochford, C.D., Neumann, H., Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J. Exp. Med. 201 (2005), 647–657.
240. Takatsuru, Y., et al. Early-life stress increases the motility of microglia in adulthood. J. Physiol. Sci. 65 (2015), 187–194.
241. Takeuchi, H., Kawashima, R., Neural mechanisms and children's intellectual development: multiple impacts of environmental factors. Neuroscientist 22 (2016), 618–631.
242. Tata, D.A., Marciano, V.A., Anderson, B.J., Synapse loss from chronically elevated glucocorticoids: relationship to neuropil volume and cell number in hippocampal area CA3. J. Comp. Neurol. 498 (2006), 363–374.
243. Tay, T.L., et al. Microglia across the lifespan: from origin to function in brain development, plasticity and cognition. J. Physiol., 2016.
244. Tian, L., et al. Shedded neuronal ICAM-5 suppresses T-cell activation. Blood 111 (2008), 3615–3625.
245. Torres, L., et al. Dynamic microglial modulation of spatial learning and social behavior. Brain Behav. Immun., 2015.
246. Torres-Platas, S.G., et al. Evidence for increased microglial priming and macrophage recruitment in the dorsal anterior cingulate white matter of depressed suicides. Brain Behav. Immun. 42 (2014), 50–59.
247. Townsend, B.E., Johnson, R.W., Sulforaphane induces Nrf2 target genes and attenuates inflammatory gene expression in microglia from brain of young adult and aged mice. Exp. Gerontol. 73 (2016), 42–48.
248. Tremblay, M.E., Lowery, R.L., Majewska, A.K., Microglial interactions with synapses are modulated by visual experience. PLoS Biol., 8, 2010, e1000527.
249. Tremblay, M.E., et al. Effects of aging and sensory loss on glial cells in mouse visual and auditory cortices. Glia 60 (2012), 541–558.
250. Tynan, R.J., et al. Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions. Brain Behav. Immun. 24 (2010), 1058–1068.
251. Tyrka, A.R., et al. Childhood maltreatment and telomere shortening: preliminary support for an effect of early stress on cellular aging. Biol. Psychiatry 67 (2010), 531–534.
252. Ueno, M., Yamashita, T., Bidirectional tuning of microglia in the developing brain: from neurogenesis to neural circuit formation. Curr. Opin. Neurobiol. 27 (2014), 8–15.
253. Ueno, M., et al. Layer V cortical neurons require microglial support for survival during postnatal development. Nat. Neurosci. 16 (2013), 543–551.
254. Valero, J., Paris, I., Sierra, A., Lifestyle shapes the dialogue between environment, microglia, and adult neurogenesis. ACS Chem. Nerosci. 7 (2016), 442–453.
255. Vallet, P., et al. Neuronal expression of the NADPH oxidase NOX4, and its regulation in mouse experimental brain ischemia. Neuroscience 132 (2005), 233–238.
256. Vallieres, L., et al. Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6. J. Neurosci. 22 (2002), 486–492.
257. van Berckel, B.N., et al. Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol. Psychiatry 64 (2008), 820–822.
258. Vivash, L., O'Brien, T.J., Imaging microglial activation with TSPO PET: lighting up neurologic diseases?. J. Nucl. Med. 57 (2016), 165–168.
259. Voikar, V., et al. Long-term individual housing in C57BL/6J and DBA/2 mice: assessment of behavioral consequences. Genes Brain Behav. 4 (2005), 240–252.
260. Vollert, C., et al. Exercise prevents sleep deprivation-associated anxiety-like behavior in rats: potential role of oxidative stress mechanisms. Behav. Brain Res. 224 (2011), 233–240.
261. von Bernhardi, R., Eugenin-von Bernhardi, L., Eugenin, J., Microglial cell dysregulation in brain aging and neurodegeneration. Front. Aging Neurosci., 7, 2015, 124.
262. Wahl, S.M., Wen, J., Moutsopoulos, N., TGF-beta: a mobile purveyor of immune privilege. Immunol. Rev. 213 (2006), 213–227.
263. Wahlsten, D., The hunt for gene effects pertinent to behavioral traits and psychiatric disorders: from mouse to human. Dev. Psychobiol. 54 (2012), 475–492.
264. Wake, H., et al. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J. Neurosci. 29 (2009), 3974–3980.
265. Walker, F.R., et al. Dynamic structural remodelling of microglia in health and disease: a review of the models, the signals and the mechanisms. Brain Behav. Immun. 37 (2014), 1–14.
266. Walter, J., The triggering receptor expressed on myeloid cells 2 - a molecular link of neuroinflammation and neurodegenerative diseases. J. Biol. Chem., 2015.
267. Wang, Y., et al. IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat. Immunol. 13 (2012), 753–760.
268. Wang, J., et al. Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage and oxidative stress in a rat model of Parkinson's disease. Pharmacol. Biochem. Behav. 138 (2015), 96–103.
269. Wang, Y., et al. Forsythiaside A exhibits anti-inflammatory effects in LPS-stimulated BV2 microglia cells through activation of Nrf2/HO-1 signaling pathway. Neurochem. Res. 41 (2016), 659–665.
270. Waschek, J.A., VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair. Br. J. Pharmacol. 169 (2013), 512–523.
271. Wei, R., Jonakait, G.M., Neurotrophins and the anti-inflammatory agents interleukin-4 (IL-4), IL-10, IL-11 and transforming growth factor-beta1 (TGF-beta1) down-regulate T cell costimulatory molecules B7 and CD40 on cultured rat microglia. J. Neuroimmunol. 95 (1999), 8–18.
272. Wei, L., et al. Early life stress inhibits expression of a novel innate immune pathway in the developing hippocampus. Neuropsychopharmacology 37 (2012), 567–580.
273. Wohleb, E.S., Delpech, J.C., Dynamic cross-talk between microglia and peripheral monocytes underlies stress-induced neuroinflammation and behavioral consequences. Prog. Neuropsychopharmacol. Biol. Psychiatry 79 (2017), 39–47.
274. Wohleb, E.S., et al. beta-Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J. Neurosci. 31 (2011), 6277–6288.
275. Wohleb, E.S., et al. Peripheral innate immune challenge exaggerated microglia activation, increased the number of inflammatory CNS macrophages, and prolonged social withdrawal in socially defeated mice. Psychoneuroendocrinology 37 (2012), 1491–1505.
276. Wohleb, E.S., et al. Re-establishment of anxiety in stress-sensitized mice is caused by monocyte trafficking from the spleen to the brain. Biol. Psychiatry 75 (2014), 970–981.
277. Wright, G.J., et al. Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity 13 (2000), 233–242.
278. Yang, R.J., et al. Variation in mouse basolateral amygdala volume is associated with differences in stress reactivity and fear learning. Neuropsychopharmacology 33 (2008), 2595–2604.
279. Yirmiya, R., et al. Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents. Neuropsychopharmacology 24 (2001), 531–544.
280. Yirmiya, R., Rimmerman, N., Reshef, R., Depression as a microglial disease. Trends Neurosci. 38 (2015), 637–658.
281. Yoo, K.Y., et al. Antioxidant enzymes are differently changed in experimental ischemic hippocampal CA1 region following repeated restraint stress. J. Neurol. Sci. 302 (2011), 33–42.
282. Zagorska, A., et al. Diversification of TAM receptor tyrosine kinase function. Nat. Immunol. 15 (2014), 920–928.
283. Zhan, Y., et al. Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior. Nat. Neurosci. 17 (2014), 400–406.
284. Zhang, X.Y., et al. Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics. Schizophr. Res. 81 (2006), 291–300.
285. Zhang, S., et al. CD200-CD200R dysfunction exacerbates microglial activation and dopaminergic neurodegeneration in a rat model of Parkinson's disease. J. Neuroinflammation, 8, 2011, 154.
286. Zhang, H., et al. SIRP/CD47 signaling in neurological disorders. Brain Res. 1623 (2015), 74–80.
287. Zhao, Q., et al. Phenotypic dysregulation of microglial activation in young offspring rats with maternal sleep deprivation-induced cognitive impairment. Sci. Rep., 5, 2015, 9513.
288. Ziv, Y., Schwartz, M., Orchestrating brain-cell renewal: the role of immune cells in adult neurogenesis in health and disease. Trends Mol. Med. 14 (2008), 471–478.
289. Zugno, A.I., et al. Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia. Neuroscience 259 (2014), 223–231.
290. Zujovic, V., et al. In vivo neutralization of endogenous brain fractalkine increases hippocampal TNFalpha and 8-isoprostane production induced by intracerebroventricular injection of LPS. J. Neuroimmunol. 115 (2001), 135–143.